Followers | 251 |
Posts | 50151 |
Boards Moderated | 47 |
Alias Born | 08/29/2007 |
Saturday, February 24, 2024 3:42:56 PM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent KROS News
- Keros Therapeutics to Present at the 29th Annual Congress of the European Hematology Association • GlobeNewswire Inc. • 05/14/2024 02:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 12:03:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 12:01:24 PM
- Keros Therapeutics Reports Recent Business Highlights and First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/08/2024 12:00:00 PM
- Keros Therapeutics Announces U.S. FDA Fast Track Designation for KER-050 in Lower-Risk Myelodysplastic Syndromes • GlobeNewswire Inc. • 03/14/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 01:01:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 01:02:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 01:01:00 PM
- Keros Therapeutics to Present at Leerink Partners 2024 Global Biopharma Conference • GlobeNewswire Inc. • 03/05/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 09:02:36 PM
- Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 02/28/2024 09:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 10:07:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 01:41:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 01:40:02 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 01:38:50 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 01:37:12 AM
- Keros Therapeutics To Present at Pulmonary Vascular Research Institute 2024 Annual Congress • GlobeNewswire Inc. • 01/29/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 01:01:24 PM
- Keros Therapeutics Announces Closing of Upsized Public Offering of Common Stock • GlobeNewswire Inc. • 01/09/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 09:43:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 09:04:12 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/04/2024 09:04:07 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/04/2024 09:02:25 PM
- Keros Therapeutics Announces Pricing of Upsized Public Offering of Common Stock • GlobeNewswire Inc. • 01/04/2024 02:29:25 AM
- Keros Therapeutics Announces Proposed Public Offering of Common Stock • GlobeNewswire Inc. • 01/03/2024 09:05:39 PM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM